Memorial Sloan Kettering Cancer CenterBoston, MA
Disclosures:
226 - Toward Adaptive Dose Painting with Hypoxia Biomarkers: Feasibility of Oxygen-Enhanced (OE)-MRI T1 Mapping on Low-Field MR-Linac
Monday, September 30, 20243:10 PM – 3:20 PM ET